The MedTech Tndustry is no stranger to change.
Increasing customer demands coupled with reduced budgets, higher targets and new technologies are requiring organizations to think differently and pivot seamlessly — all while balancing risk.
A new challenge the MedTech industry is facing is how to plan for the aging workforce crisis among field service engineers.
In a study conducted in 2017 by The Service Council, 50 percent of MedTech business leaders indicated the talent shortage will become "extremely critical in the next 5-10 years."1
This approaching talent shortage is forcing medical device and diagnostic manufacturers to explore and implement the following options:
- Automate, optimize and streamline field service productivity with new technologies
- Adapt existing recruitment and development plans to hire and train new talent
- Outsource the field service arm of the business to a trusted, third-party provider
Technology and Service Excellence
Understanding the role technology plays is important, but it has limitations with regard to delivering service excellence and driving customer satisfaction. At its core, field service is a business driven by people.
In addition, the expectation for delivering exceptional, personalized customer service with communication that meets the customers' expectation is higher than ever. Organizations like Tesla and Apple are setting a new standard for service excellence and manufacturers are looking to elevate their service delivery at every opportunity, including their field technical support. Further, Materials Management, Environmental Services and Biomedical customers expect nothing less than personalized service and support that addresses their immediate need and reinforces a joint partnership. This level of service excellence is delivered by the team and streamlined by the technology.
Developing a Formalized Workforce Succession Plan
MedTech manufacturers are facing several key challenges and opportunities when developing their formalized workforce succession plans to attract, train and retain new talent.
- Investment in Knowledge Capture - With an increase in talent turnover, organizations are attempting to find new methods and tools to capture and retain resolution practices.2 This would allow them to, in turn, educate the new talent coming on board.
- Length of Onboarding - In a study conducted by Field Service News from 164 field service engineers across multiple industries, respondents indicated three-to-six months as the typical duration of onboading for 55 percent of respondents, with 34 percent indicating an onboarding cycle of one-to-two years.3 This extended onboarding time frame increases the urgency for developing the succession plan and identifying the appropriate talent that would support the role in the long-term.
- Millennial Adjustments - When assessing the talent pool, organizations are exploring all avenues for finding talent with this skilled trade — from technical college graduates to military veterans. One of the largest obstacles organizations face is that millennials have different priorities than those currently retiring from the profession — including the priority of work-life-balance over financial remuneration and the value placed on a diversified career path.3
- Training Methodology - Beyond mentor and shadowing programs that pair retiring workers with new employees, the Field Service News study indicates organizations are more recently utilizing video conferencing and augmented reality training methods as they allow for increased flexibility and part-time support.3
Outsourcing with a Third Party
One of the primary study conclusions in the Field Service News study is that there is a gradual shift in workforce dynamics whereby field service support services has become increasingly outsourced.3
MedTech manufacturers today are looking for partners, like Novasyte, who are able to attract, train and retain only the highest-quality field technicians to support their maintenance, upgrade and repair support.
In May 2018, the FDA released a report that examined product servicing by manufacturers, healthcare establishments and third-party providers who refurbish, recondition, rebuild, remarket, service and repair medical devices. Two key findings were highlighted:
- "The objective evidence indicates that many OEMs and third party entities provide high quality, safe, and effective servicing of medical devices, and
- The continued availability of third party entities to service and repair medical devices is critical to the functioning of the U.S. healthcare system."4
Today, Novasyte supports many of the largest medical device and diagnostic players in the industry and has also experienced a significant increase in field technical outsourcing in recent years. Our network of 2,200 consultants throughout the US and Canada help us to support our clients with custom, dedicated programs that scale quickly and provide the highest-quality service under W-2 employment classification. Additionally, we actively recruit veterans through our partnership with MVPvets, an organization that serves as a bridge between men and women transitioning out of the military and life science organizations.
To learn more about Novasyte's Field Technical Program, watch this 60-second video.
1. Dutta, S. (2017, March 9). Field service talent shortage part 1: The growing concern. _Click Software._ Retrieved from https://www.clicksoftware.com/blog/field-service-talent-shortage-part-1-the-growing-concern/
2. Dutta, S. (2014, July 16). The looming crisis in field service. _The Service Council._ Retrieved from http://servicecouncil.com/the-looming-crisis-in-field-service/
3. Oldland, K. (2018, July 23). The ageing workforce crisis is not only real but it's here- How are we going to resolve it? _Field Service News._ Retrieved from http://fieldservicenews.com/the-ageing-workforce-crisis-is-not-only-real-but-its-here-how-are-we-going-to-resolve-it-part-two/
4. The U.S. Food & Drug Administration. (2018 May). FDA report on the quality, safety, and effectiveness of servicing of medical devices: In accordance with section 710 of the Food and Drug Administration Reauthorization Act of 2017 (FDARA). _The U.S. Food & Drug Administration._ Retrieved from https://www.fda.gov/downloads/RegulatoryInformation/LawsEnforcedbyFDA/SignificantAmendmentstotheFDCAct/FDARA/UCM607469.pdf